Study of DITPA in Patients With Congestive Heart Failure

NCT00103519 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

86

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated for reasons unrelated to safety or efficacy.

Conditions

Heart Failure, Congestive

Interventions

DRUG: DITPA (3,5-diiodothyropropionic acid)
DRUG: Placebo

Sponsor

Titan Pharmaceuticals